India markets open in 41 minutes
  • BSE SENSEX

    52,586.84
    -66.26 (-0.13%)
     
  • Nifty 50

    15,763.05
    -15.45 (-0.10%)
     
  • Dow

    34,935.47
    -149.03 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.62 (-0.71%)
     
  • BTC-INR

    2,966,281.00
    -147,325.25 (-4.73%)
     
  • CMC Crypto 200

    965.90
    +16.00 (+1.68%)
     
  • Hang Seng

    26,136.41
    +175.38 (+0.68%)
     
  • Nikkei

    27,742.28
    +458.69 (+1.68%)
     
  • EUR/INR

    88.3166
    +0.0438 (+0.05%)
     
  • GBP/INR

    103.3368
    -0.0247 (-0.02%)
     
  • AED/INR

    20.2040
    +0.0100 (+0.05%)
     
  • INR/JPY

    1.4718
    -0.0003 (-0.02%)
     
  • SGD/INR

    54.9510
    +0.0480 (+0.09%)
     

Brazil expects first Sputnik V deliveries in early July: Governor

·1-min read
Representative Image
Representative Image

Mexico City [Mexico], June 16 (ANI/Sputnik): The first batches of the Russian Sputnik V coronavirus vaccine are expected to be delivered to Brazil in early July, Camilo Santana, governor of the Brazilian state of Ceara, announced on Tuesday.

"This morning, there was a meeting between representatives of the Russian Direct Investment Fund, responsible for the Sputnik V vaccine, and the governors of the North-East (Brazil). The Fund confirmed the deliveries of the first doses of the vaccine in early July, and the dose distribution schedule will be ready by the end of this month," Santana tweeted.

The RDIF head, Kirill Dmitriev, confirmed earlier that the supplies of the Russian vaccine to Brazil will begin in July.

On June 5, the Brazilian Health Regulatory Agency Anvisa has approved the import and emergency use of the Russian Sputnik V with a number of restrictions. The drug has been long sought by the governors of six Brazilian states, the Brazilian interregional development consortium and Brazilian lab Uniao Quimica, which is already producing the vaccine.

Sputnik V has been so far approved in 67 countries with a total population of over 3.4 billion people. The Russian vaccine ranks second in the world in terms of the number of approvals by government regulators.

The effectiveness of the vaccine is 97.6 per cent based on the analysis of data from 3.8 million vaccinated Russians, which is higher than the data previously published by medical journal The Lancet (91.6 per cent). (ANI/Sputnik)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting